Global Digital Therapeutics Market: Industry Analysis and Forecast (2021-2027) Type, Input Type, Equipment and Crop Type.

Global Digital Therapeutics Market size was valued at US$ 2.59 Bn. in 2020 and the total revenue is expected to grow at 31.4 % CAGR through 2021 to 2027, reaching nearly US$ 17.52 Bn.

Global Digital Therapeutics Market Overview:

Patients can receive evidence-based therapeutic input from digital therapies, which focuses on the treatment of diseases through programmes and management utilising high-quality software. AI's application in healthcare has opened up a whole new universe of possibilities, and it's still growing in terms of capabilities, scope, and size. AI plays a crucial role in enabling personalisation and engagement to assist patients achieve improved health in the digital therapeutics market, where almost 200 new apps are released every day. Global Digital Therapeutics Market To know about the Research Methodology :- Request Free Sample Report 2020 is considered as a base year to forecast the Market from 2021 to 2027. 2020’s Market size is estimated on real numbers and outputs of the key players and major players across the globe. Past five years trends are considered while forecasting the Market through 2027. 2020 is a year of exception and analyzed specially with the impact of lockdown by region.

Global Digital Therapeutics Market Dynamics:

According to FDA guidelines issued in April 2020, this will allow the distribution and use of digital devices to treat mental health conditions during a pandemic. As a result, more and more suppliers and consumers are turning to digital remedies. The COVID-19 outbreak is projected to have a beneficial impact on the global digital therapeutics (DTx) market's growth. Digital therapies have a lot of potential in emerging economies like India, China, and the Middle East. Due to a lack of awareness, the limited availability of these solutions, a lack of IT infrastructure, and financial and social restraints, the market is still in its infancy in most geographies. On the other hand, chronic disease is prevalent in most rising economies. chronic disease are expected to account for 70% of all fatalities in developing nations by 2020, according to WHO estimates. By 2025, developing countries will account for 60 % of the global burden of chronic diseases. Another factor that is expected to propel the industry forward is mental health. The epidemic exacerbated mental health issues, highlighting the need for new treatment alternatives. This opens up a lot of doors for digital therapeutics firms. For example, the US Food and Drug Administration (FDA) granted Nightware, a digital therapeutics company, marketing permission in November 2020 for the temporary decrease of sleep disturbance in Post-traumatic Stress Disorder (PTSD) patients. Another key technological driver for the market for digital therapeutics is the rise in smartphone and internet usage among consumers. According to a research published by the India Cellular and Electronics Association in July 2020, the Indian market is the world's fastest-growing application market. The industry has a lot of room for expansion. As a result, a slew of digital therapeutics startups with cutting-edge products and technologies have emerged. Pear Therapeutics, Inc., Mindable, Bold Health, BehaVR, Naluri, and Kelvi are just a few of them.

Global Digital Therapeutics Market Segment Analysis:

Based on sales channel, Digital Therapeutics market is segmented into B2B and B2C. B2B segment is expected to hold the largest share in the global Digital Therapeutics market during the forecast period. B2B is sub segmented into Providers, Payers, Employers, Pharmaceutical Companies and Other Buyers. A key element driving the growth of this market is pharmaceutical companies' propensity for integrating digital treatments with their medicinal products to provide adherence services. Furthermore, increased awareness of the benefits of digital pharmaceuticals among payers, employers, and providers has aided market expansion. Global Digital Therapeutics MarketBased on input type, based on raw material the Digital Therapeutics market is segmented into Preventive Applications and Treatment/Care-Related Applications. During the forecast period Treatment/Care-Related Applications segment is expected to grow at fastest CAGR. It is further sub segmented into Diabetes, CNS Disorders, Chronic Respiratory Disorders and Smoking Cessation. In 2020, the diabetes sector dominated the digital therapeutics market, with a revenue share of more than 28.0 percent. During the projected period, this category is expected to increase at the fastest rate. Diabetes is becoming more common in the world's population, which is fueling this growth. According to the International Diabetes Federation (IDF), 463 million people worldwide have diabetes in 2019, with 700 million projected by 2045. This is projected to boost the demand for related digital therapeutics solutions.

Global Digital Therapeutics MarketGlobal Digital Therapeutics MarketGlobal Digital Therapeutics Market Regional Insights:

North America had held the biggest market share in 2020, followed by Europe. North America's market is predicted to increase at the fastest rate owing to entry of new startups, rising investments in digital therapeutics, changes in the reimbursement structure for digital therapeutics, and government initiatives to assist technical advancements. Apple and Google will collaborate in April 2020 to develop a new app-based contact tracing mechanism. It is the procedure of locating those who have contact with sick patients and ensuring that they are tested or placed in quarantine. In June 2020, MedRhythms, a digital therapeutics firm based in Portland, Maine, got FDA approval for their unique digital therapy to address persistent stroke walking deficits. Asia Pacific is expected to have the highest CAGR during forecast period thanks to its large population. This suggests that the producers are targeting a huge portion of the population. Furthermore, a big number of emerging-market governments are supporting the adoption of market products and offering financial aid. As a result, demand has increased, and the region continues to expand. Large usage of smartphones is another factor which is propelling the growth of digital therapeutics market. Pear Therapeutics launched the ReSet for the treatment of substance dependence in January 2020. A big number of investors have spent USD 12.5 billion into digital health enterprises in the United States as digital therapies have progressed from concept to reality. Fitbit bought Twine Health in February 2020. Fitbit will use the acquisition to enhance its healthcare service and establish the groundwork for expanding its offering to health systems, health plans, and self-insured companies, as well as increase subscription-based revenue. Fitbit's technology for achieving long-term behaviour change will be combined with Twine Health's clinical expertise in this transaction. Welldoc(US) partnered with Dexacom (US) in April 2021, This partnership helped to provide BlueStar with Dexcom G6 CGM as a single platform to people with Type 2 diabetes for improved health. Global Digital Therapeutics MarketGlobal Digital Therapeutics MarketThe objective of the report is to present a comprehensive analysis of the Global Digital Therapeutics Market to the stakeholders in the industry. The past and current status of the industry with the forecasted Market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include Market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the Market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Digital Therapeutics Market dynamics, structure by analyzing the Market segments and project the Global Digital Therapeutics Market size. Clear representation of competitive analysis of key players by Type, price, financial position, Type portfolio, growth strategies, and regional presence in the Global Digital Therapeutics Market make the report investor’s guide.

Global Digital Therapeutics Market Scope: Inquire before buying

Global Digital Therapeutics MarketGlobal Digital Therapeutics Market

Global Digital Therapeutics Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Global Digital Therapeutics Market Key Players

Evolent Health, Inc.Pear Therapeutics, Inc. WellDoc Inc.Nanobiosym, Inc. • Twine Health, Inc. • Mango Health Inc. • Canary Health Inc. • 2morrow Inc. • Propeller Health • Ginger.Io, Inc. • Noom Inc. • Livongo Health • Welldoc, Inc. • Omada Health, Inc. • Proteus Digital Health, Inc. • Akili Interactive Labs • Better Therapeutics • Happify • Kaia Health • Click Therapeutics • Wellthy Therapeutics • Cognoa • Ayogo Health

Frequently Asked Questions:

1] What segments are covered in Global Digital Therapeutics Market report? Ans. The segments covered in Global Digital Therapeutics Market report are based on sales channel and application. 2] Which region is expected to hold the highest share in the Global Digital Therapeutics Market? Ans. Europe is expected to hold the highest share in the Global Digital Therapeutics Market. 3] What is the Market size of Global Digital Therapeutics Market in 2027? Ans. The Market size of Global Digital Therapeutics Market in the forecast period 2027 is US $ 17.52 Bn. 4] Who are the top key players in the Global Digital Therapeutics Market? Ans. Evolent Health, Health, Inc., Mango Health Inc., Canary Health Inc., 2morrow Inc., Propeller Health, Ginger.Io, Inc., Noom Inc., Livongo Health, Welldoc, Inc., Omada Health, Inc. 5] What was the Market size of Global Digital Therapeutics Market in 2020? Ans. The Market size of Global Digital Therapeutics Market in 2020 was US $ 2.59 Bn.

Global Digital Therapeutics Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. Global Digital Therapeutics Market Size, by Market Value (US$ Mn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 5. Global Digital Therapeutics Market Analysis and Forecast 5.1. Global Digital Therapeutics Market Analysis and Forecast 5.2. Global Digital Therapeutics Market Size& Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. Latin America 6. Global Digital Therapeutics Market Analysis and Forecast, by Sales Channel 6.1. Introduction and Definition 6.2. Key Findings 6.3. Global Digital Therapeutics Market Value Share Analysis, by Sales Channel 6.4. Market Size (US$ Mn) Forecast, by Sales Channel 6.5. Global Digital Therapeutics Market Analysis, by Sales Channel 6.6. Digital Therapeutics Market Attractiveness Analysis, by Sales Channel 7. Global Digital Therapeutics Market Analysis and Forecast, by Application 7.1. Introduction and Definition 7.2. Global Digital Therapeutics Market Value Share Analysis, by Application 7.3. Market Size (US$ Mn) Forecast, by Application 7.4. Global Digital Therapeutics Market Analysis, by Application 7.5. Global Digital Therapeutics Market Attractiveness Analysis, by Application 8. Global Digital Therapeutics Market Analysis, by Region 8.1. Global Digital Therapeutics Market Value Share Analysis, by Region 8.2. Market Size (US$ Mn) Forecast, by Region 8.3. Global Digital Therapeutics Market Attractiveness Analysis, by Region 9. North America Digital Therapeutics Market Analysis 9.1. Key Findings 9.2. North America Digital Therapeutics Market Overview 9.3. North America Digital Therapeutics Market Value Share Analysis, by Sales Channel 9.4. North America Digital Therapeutics Market Forecast, by Sales Channel 9.4.1. B2B 9.4.2. B2C 9.5. North America Digital Therapeutics Market Value Share Analysis, by Application 9.6. North America Digital Therapeutics Market Forecast, by Application 9.6.1. Preventive Applications 9.6.2. Treatment/Care-Related Applications 9.7. North America Digital Therapeutics Market Value Share Analysis, by Country 9.8. North America Digital Therapeutics Market Forecast, by Country 9.8.1. U.S. 9.8.2. Canada 9.9. North America Digital Therapeutics Market Analysis, by Country 9.10. U.S. Digital Therapeutics Market Forecast, by Sales Channel 9.10.1. B2B 9.10.2. B2C 9.11. U.S. Digital Therapeutics Market Forecast, by Application 9.11.1. Preventive Applications 9.11.2. Treatment/Care-Related Applications 9.12. Canada Digital Therapeutics Market Forecast, by Sales Channel 9.12.1. B2B 9.12.2. B2C 9.13. Canada Digital Therapeutics Market Forecast, by Application 9.13.1. Preventive Applications 9.13.2. Treatment/Care-Related Applications 9.14. North America Digital Therapeutics Market Attractiveness Analysis 9.14.1. By Sales Channel 9.14.2. By Application 9.15. PEST Analysis 10. Europe Digital Therapeutics Market Analysis 10.1. Key Findings 10.2. Europe Digital Therapeutics Market Overview 10.3. Europe Digital Therapeutics Market Value Share Analysis, by Sales Channel 10.4. Europe Digital Therapeutics Market Forecast, by Sales Channel 10.4.1. B2B 10.4.2. B2C 10.5. Europe Digital Therapeutics Market Value Share Analysis, by Application 10.6. Europe Digital Therapeutics Market Forecast, by Application 10.6.1. Preventive Applications 10.6.2. Treatment/Care-Related Applications 10.7. Europe Digital Therapeutics Market Value Share Analysis, by Country 10.8. Europe Digital Therapeutics Market Forecast, by Country 10.8.1.1. Germany 10.8.1.2. U.K. 10.8.1.3. France 10.8.1.4. Italy 10.8.1.5. Spain 10.8.1.6. Rest of Europe 10.9. Europe Digital Therapeutics Market Analysis, by Country/ Sub-region 10.10. Germany Digital Therapeutics Market Forecast, by Sales Channel 10.10.1. B2B 10.10.2. B2C 10.11. Germany Digital Therapeutics Market Forecast, by Application 10.11.1. Preventive Applications 10.11.2. Treatment/Care-Related Applications 10.12. U.K. Digital Therapeutics Market Forecast, by Sales Channel 10.12.1. B2B 10.12.2. B2C 10.13. U.K. Digital Therapeutics Market Forecast, by Application 10.13.1. Preventive Applications 10.13.2. Treatment/Care-Related Applications 10.14. France Digital Therapeutics Market Forecast, by Sales Channel 10.14.1. B2B 10.14.2. B2C 10.15. France Digital Therapeutics Market Forecast, by Application 10.15.1. Preventive Applications 10.15.2. Treatment/Care-Related Applications 10.16. Italy Digital Therapeutics Market Forecast, by Sales Channel 10.16.1. B2B 10.16.2. B2C 10.17. Italy Digital Therapeutics Market Forecast, by Application 10.17.1. Preventive Applications 10.17.2. Treatment/Care-Related Applications 10.18. Spain Digital Therapeutics Market Forecast, by Sales Channel 10.18.1. B2B 10.18.2. B2C 10.19. Spain Digital Therapeutics Market Forecast, by Application 10.19.1. Preventive Applications 10.19.2. Treatment/Care-Related Applications 10.20. Rest of Europe Digital Therapeutics Market Forecast, by Sales Channel 10.20.1. B2B 10.20.2. B2C 10.21. Rest of Europe Digital Therapeutics Market Forecast, by Application 10.21.1. Preventive Applications 10.21.2. Treatment/Care-Related Applications 10.22. Europe Digital Therapeutics Market Attractiveness Analysis 10.22.1. By Sales Channel 10.22.2. By Application 10.23. PEST Analysis 11. Asia Pacific Digital Therapeutics Market Analysis 11.1. Key Findings 11.2. Asia Pacific Digital Therapeutics Market Overview 11.3. Asia Pacific Digital Therapeutics Market Value Share Analysis, by Sales Channel 11.4. Asia Pacific Digital Therapeutics Market Forecast, by Sales Channel 11.4.1. B2B 11.4.2. B2C 11.5. Asia Pacific Digital Therapeutics Market Value Share Analysis, by Application 11.6. Asia Pacific Digital Therapeutics Market Forecast, by Application 11.6.1. Preventive Applications 11.6.2. Treatment/Care-Related Applications 11.7. Asia Pacific Digital Therapeutics Market Value Share Analysis, by Country 11.8. Asia Pacific Digital Therapeutics Market Forecast, by Country 11.8.1. China 11.8.2. India 11.8.3. Japan 11.8.4. ASEAN 11.8.5. Rest of Asia Pacific 11.9. Asia Pacific Digital Therapeutics Market Analysis, by Country/ Sub-region 11.10. China Digital Therapeutics Market Forecast, by Sales Channel 11.10.1. B2B 11.10.2. B2C 11.11. China Digital Therapeutics Market Forecast, by Application 11.11.1. Preventive Applications 11.11.2. Treatment/Care-Related Applications 11.12. India Digital Therapeutics Market Forecast, by Sales Channel 11.12.1. B2B 11.12.2. B2C 11.13. India Digital Therapeutics Market Forecast, by Application 11.13.1. Preventive Applications 11.13.2. Treatment/Care-Related Applications 11.14. Japan Digital Therapeutics Market Forecast, by Sales Channel 11.14.1. B2B 11.14.2. B2C 11.15. Japan Digital Therapeutics Market Forecast, by Application 11.15.1. Preventive Applications 11.15.2. Treatment/Care-Related Applications 11.16. ASEAN Digital Therapeutics Market Forecast, by Sales Channel 11.16.1. B2B 11.16.2. B2C 11.17. ASEAN Digital Therapeutics Market Forecast, by Application 11.17.1. Preventive Applications 11.17.2. Treatment/Care-Related Applications 11.18. Rest of Asia Pacific Digital Therapeutics Market Forecast, by Sales Channel 11.18.1. B2B 11.18.2. B2C 11.19. Rest of Asia Pacific Digital Therapeutics Market Forecast, by Application 11.19.1. Preventive Applications 11.19.2. Treatment/Care-Related Applications 11.20. Asia Pacific Digital Therapeutics Market Attractiveness Analysis 11.20.1. By Sales Channel 11.20.2. By Application 11.21. PEST Analysis 12. Middle East & Africa Digital Therapeutics Market Analysis 12.1. Key Findings 12.2. Middle East & Africa Digital Therapeutics Market Overview 12.3. Middle East & Africa Digital Therapeutics Market Value Share Analysis, by Sales Channel 12.4. Middle East & Africa Digital Therapeutics Market Forecast, by Sales Channel 12.4.1. B2B 12.4.2. B2C 12.5. Middle East & Africa Digital Therapeutics Market Value Share Analysis, by Application 12.6. Middle East & Africa Digital Therapeutics Market Forecast, by Application 12.6.1. Preventive Applications 12.6.2. Treatment/Care-Related Applications 12.7. Middle East & Africa Digital Therapeutics Market Value Share Analysis, by Country 12.8. Middle East & Africa Digital Therapeutics Market Forecast, by Country 12.8.1. GCC 12.8.2. South Africa 12.8.3. Rest of Middle East & Africa 12.9. Middle East & Africa Digital Therapeutics Market Analysis, by Country/ Sub-region 12.10. GCC Digital Therapeutics Market Forecast, by Sales Channel 12.10.1. B2B 12.10.2. B2C 12.11. GCC Digital Therapeutics Market Forecast, by Application 12.11.1. Preventive Applications 12.11.2. Treatment/Care-Related Applications 12.12. South Africa Digital Therapeutics Market Forecast, by Sales Channel 12.12.1. B2B 12.12.2. B2C 12.13. South Africa Digital Therapeutics Market Forecast, by Application 12.13.1. Preventive Applications 12.13.2. Treatment/Care-Related Applications 12.14. Rest of Middle East & Africa Digital Therapeutics Market Forecast, by Sales Channel 12.14.1. B2B 12.14.2. B2C 12.15. Rest of Middle East & Africa Digital Therapeutics Market Forecast, by Application 12.15.1. Preventive Applications 12.15.2. Treatment/Care-Related Applications 12.16. Middle East & Africa Digital Therapeutics Market Attractiveness Analysis 12.16.1. By Sales Channel 12.16.2. By Application 12.17. PEST Analysis 13. Latin America Digital Therapeutics Market Analysis 13.1. Key Findings 13.2. Latin America Digital Therapeutics Market Overview 13.3. Latin America Digital Therapeutics Market Value Share Analysis, by Sales Channel 13.4. Latin America Digital Therapeutics Market Forecast, by Sales Channel 13.4.1. B2B 13.4.2. B2C 13.5. Latin America Digital Therapeutics Market Value Share Analysis, by Application 13.6. Latin America Digital Therapeutics Market Forecast, by Application 13.6.1. Preventive Applications 13.6.2. Treatment/Care-Related Applications 13.7. Latin America Digital Therapeutics Market Value Share Analysis, by Country 13.8. Latin America Digital Therapeutics Market Forecast, by Country 13.8.1. Brazil 13.8.2. Mexico 13.8.3. Rest of Latin America 13.9. Latin America Digital Therapeutics Market Analysis, by Country/ Sub-region 13.10. Brazil Digital Therapeutics Market Forecast, by Sales Channel 13.10.1. B2B 13.10.2. B2C 13.11. Brazil Digital Therapeutics Market Forecast, by Application 13.11.1. Preventive Applications 13.11.2. Treatment/Care-Related Applications 13.12. Mexico Digital Therapeutics Market Forecast, by Sales Channel 13.12.1. B2B 13.12.2. B2C 13.13. Mexico Digital Therapeutics Market Forecast, by Application 13.13.1. Preventive Applications 13.13.2. Treatment/Care-Related Applications 13.14. Rest of Latin America Digital Therapeutics Market Forecast, by Sales Channel 13.14.1. B2B 13.14.2. B2C 13.15. Rest of Latin America Digital Therapeutics Market Forecast, by Application 13.15.1. Preventive Applications 13.15.2. Treatment/Care-Related Applications 13.16. Latin America Digital Therapeutics Market Attractiveness Analysis 13.16.1. By Sales Channel 13.16.2. By Application 13.17. PEST Analysis 14. Company Profiles 14.1. Market Share Analysis, by Company 14.2. Competition Matrix 14.3. Company Profiles: Key Players 14.3.1. Evolent Health, Inc. 14.3.1.1. Company Overview 14.3.1.2. Financial Overview 14.3.1.3. Business Strategy 14.3.1.4. Recent Developments 14.3.1.5. Manufacturing Footprint 14.3.2. Pear Therapeutics, Inc. 14.3.3. WellDoc Inc. 14.3.4. Nanobiosym, Inc. 14.3.5. Twine Health, Inc. 14.3.6. Mango Health Inc. 14.3.7. Canary Health Inc. 14.3.8. 2morrow Inc. 14.3.9. Propeller Health 14.3.10. Ginger.Io, Inc. 14.3.11. Noom Inc. 14.3.12. Livongo Health 14.3.13. Welldoc, Inc. 14.3.14. Omada Health, Inc. 14.3.15. Proteus Digital Health, Inc. 14.3.16. Akili Interactive Labs 14.3.17. Better Therapeutics 14.3.18. Happify 14.3.19. Kaia Health 14.3.20. Click Therapeutics 14.3.21. Wellthy Therapeutics 14.3.22. Cognoa 14.3.23. Ayogo Health 15. Primary Key Insights

About This Report

Report ID7003
Category Healthcare
Published DateJan 2020
Updated DateSep 2021
Contact Us